- Home
- ATOS vs JAKK Comparison
ATOS vs JAKK Comparison
Compare ATOS & JAKK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ATOS
- JAKK
- Stock Information
- Founded
- ATOS 2009
- JAKK 1995
- Country
- ATOS United States
- JAKK United States
- Employees
- ATOS N/A
- JAKK N/A
- Industry
- ATOS Biotechnology: Pharmaceutical Preparations
- JAKK Recreational Games/Products/Toys
- Sector
- ATOS Health Care
- JAKK Consumer Discretionary
- Exchange
- ATOS Nasdaq
- JAKK Nasdaq
- Market Cap
- ATOS 174.8M
- JAKK 200.6M
- IPO Year
- ATOS 2012
- JAKK 1996
- Fundamental
- Price
- ATOS $1.54
- JAKK $29.23
- Analyst Decision
- ATOS Strong Buy
- JAKK Strong Buy
- Analyst Count
- ATOS 3
- JAKK 4
- Target Price
- ATOS $6.25
- JAKK $41.25
- AVG Volume (30 Days)
- ATOS 502.2K
- JAKK 111.9K
- Earning Date
- ATOS 11-19-2024
- JAKK 10-30-2024
- Dividend Yield
- ATOS N/A
- JAKK N/A
- EPS Growth
- ATOS N/A
- JAKK N/A
- EPS
- ATOS N/A
- JAKK 2.99
- Revenue
- ATOS N/A
- JAKK $687,697,000.00
- Revenue This Year
- ATOS N/A
- JAKK N/A
- Revenue Next Year
- ATOS N/A
- JAKK $3.56
- P/E Ratio
- ATOS N/A
- JAKK $10.11
- Revenue Growth
- ATOS N/A
- JAKK N/A
- 52 Week Low
- ATOS $0.62
- JAKK $17.06
- 52 Week High
- ATOS $2.31
- JAKK $36.84
- Technical
- Relative Strength Index (RSI)
- ATOS 65.98
- JAKK 66.97
- Support Level
- ATOS $1.36
- JAKK $27.82
- Resistance Level
- ATOS $1.66
- JAKK $30.83
- Average True Range (ATR)
- ATOS 0.07
- JAKK 1.25
- MACD
- ATOS 0.02
- JAKK 0.24
- Stochastic Oscillator
- ATOS 80.65
- JAKK 68.12
About ATOS Atossa Therapeutics Inc.
Atossa Therapeutics Inc is a clinical stage biopharmaceutical company developing proprietary innovative medicines in areas of unmet medical need in oncology. It focuses on the development of novel therapeutics and delivery methods for the treatment of breast cancer, other breast conditions and COVID-19. The company's drug under development for breast cancer and other breast conditions is Endoxifen. Its two COVID-19 drugs under development are AT-H201, to improve lung function of moderate to severely ill, hospitalized COVID-19 patients by inhalation; and AT-301, a nasal spray for COVID-19 patients for at-home use.
About JAKK JAKKS Pacific Inc.
Jakks Pacific Inc is a multi-brand toy company that designs, produces, markets, and distributes toys and related products, consumables, and related products, electronics and related products, kids' indoor and outdoor furniture, and other consumer products. Its products offering include Traditional toys and electronics such as Action figures, Toy vehicles, Dolls and accessories, Ride-on toys, Toys for pets, and others.